Study guide

Genetic testing, research and organ donation

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Genetic testing, research and organ donation

Key Takeaways Explain This Topic AI

A genetic variant of uncertain significance is not a confirmed pathogenic diagnosis.

Indigenous genomic research needs attention to community governance and DNA sovereignty.

Death determination and donation consent are distinct clinical and legal processes.

Last updated: October 2026

Genetic consent and interpretation

Before genetic testing, clarify the clinical question, possible results, limitations and how findings may affect the person and relatives. Diagnostic testing, carrier screening and predictive testing have different purposes. Discuss uncertainty, incidental findings, privacy and current legal/insurance implications through a qualified service when relevant. A variant of uncertain significance is not proof of disease and should not automatically drive major irreversible treatment. Family history and phenotype remain important; a negative panel does not exclude every inherited disorder.

Predictive testing for a serious adult-onset condition needs careful counselling and voluntariness. Do not assume that a relative's wish to know overrides the patient's choices. Testing a child requires an assessment of present benefit, consent and future autonomy rather than routine testing for every adult-onset risk. Direct-to-consumer reports may have limited analytical/clinical validity; confirm through an appropriate accredited clinical pathway before treatment. Discuss reproductive options and family communication without coercion or implying that a genetic finding defines the person's worth.

Relatives, confidentiality and DNA sovereignty

Encourage patients to share actionable hereditary information with relatives, offering support and clear explanation. Confidentiality exceptions require the specific legal framework, risk assessment and expert advice; genetic relatedness is not a blanket permission to release the whole record. Relatives may have a right not to know. Separate the minimum information needed to address risk from unrelated personal details. Document advice and the rationale when difficult competing interests arise rather than applying a memorised slogan.

For research involving Aboriginal and Torres Strait Islander peoples, individual consent is necessary but may not settle collective rights concerning samples, data and knowledge. Engage communities in governance, purpose, collection, storage, access, secondary use, benefit and return of results. DNA sovereignty includes control and self-determination over genetic resources and information, not merely a signed hospital form. Do not assume one community representative speaks for all peoples. Use relevant NHMRC and AIATSIS guidance and community-led processes, including the implications of overseas repositories and future reuse.

Human research

Research requires appropriate ethics review and institutional governance, with a scientifically sound question, fair recruitment and an acceptable risk/benefit balance. The current NHMRC National Statement is the 2025 version, effective from 23 June 2026. Explain randomisation, placebo/control, extra procedures, alternatives and the distinction between research and individual treatment. A clinician-researcher must avoid implying that participation is required to receive ordinary care. Payment should not become undue influence, especially in vulnerable populations.

Consent is an ongoing process, with the ability to withdraw subject to explained limits such as already analysed de-identified data. Capacity, interpreter needs and dependency relationships require attention. Some research can have approved consent modifications, but investigators cannot invent their own waiver because recruitment is difficult. Report adverse events and manage protocol changes through the relevant approvals. Distinguish research from audit or quality improvement using the institution's governance requirements; calling a project an “audit” does not automatically remove ethical obligations.

Organ and tissue donation

Donation decisions require appropriate consent, legal processes and trained teams. Assessment of death follows the accepted neurological or circulatory determination framework; coma, severe disability and a do-not-resuscitate order are not themselves death. Exclude relevant confounders for neurological determination and use the specialist standards. Decisions to limit burdensome treatment should be made independently of organ-retrieval interests. Contact the donation service when potential donation is relevant rather than making unsupported bedside assumptions about eligibility.

Discuss donation sensitively with families, respecting cultural, religious and individual preferences and accurate information about the patient's known wishes. Registration is useful but the lawful consent and practical pathway must still be followed. Tissue donation can have different eligibility/timing from solid-organ donation. Living donation adds the donor's independent welfare, voluntariness and risk; family pressure or financial inducement must be addressed. Transplant allocation should use transparent authorised criteria rather than an individual clinician's personal view of social worth.

Applied ethical reasoning

A patient with a consumer “high-risk mutation” report needs clinical validation and counselling before prophylactic surgery. A researcher proposing future genomic reuse beyond the original consent needs governance and consent assessment, including collective interests where relevant. A deeply unconscious ventilated patient cannot be called brain-dead from appearance alone. A relative offering an organ deserves independent assessment of pressure and risks. Each example tests whether consent, validity and governance are applied to the particular action rather than treated as an administrative signature.

Document the patient's decisions, the scope of testing/use and who will communicate results. Provide a contact for later questions and changes of preference. Clinicians should recognise the limits of their genetic or donation expertise and obtain suitable help, while continuing ordinary care and support. Appropriate referral is an active part of safe practice, not abandonment.

NHMRC National Statement , Indigenous research ethics and DonateLife professional statements .

Review checkpoints

A genetic variant of uncertain significance is not a confirmed pathogenic diagnosis.

Indigenous genomic research needs attention to community governance and DNA sovereignty.

Death determination and donation consent are distinct clinical and legal processes.